Patent · US Expired

Parenterally administerable liposome formulation comprising synthetic lipid

US5270053A · kind A · utility

20Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 1992
Grant dateDec 14, 1993
Priority date
Expiry dateDec 9, 2012

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2984
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to pharmaceutical compositions in the form of parenterally, especially intravenously, administrable liposome dispersions or dry preparations, especially lyophilisates, that can be used therefor, comprising the zinc-phthalocyanine complex and synthetic, substantially pure phospholipids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.